Skip to main content

Table 2 Univariate analysis to identify the candidate risks of PEGF

From: Perioperative hemoglobin decrement as an independent risk of poor early graft function in kidney transplantation

Variables PEGF n (%) IGF n (%) Crude OR (95% CI) P-value
Cause of ESRD
 Unknown 70 (71.4) 91 (53.2) 2.19 (1.29–3.74) 0.004
 Known 28 (28.6) 80 (46.8)
Recipient baseline creatinine (mg/dL)
 >8.5 54 (56.8) 64 (39.0) 2.06 (1.23–3.44) 0.007
 ≤8.5 41 (43.2) 100 (60.9)
Pretransplant PRA (%)
 >50 24 (25.0) 15 (8.9) 3.4 (1.68–6.87) <0.001
 ≤50 72 (75.0) 153 (91.1)
Donor type
 Deceased 87 (88.8) 39 (22.8) 26.77 (13.33–56.65) <0.001
 Living 11 (11.2) 132 (77.2)
Donor age (year)
 >55 21 (21.9) 13 (7.8) 3.29 (1.57–6.94) 0.002
 ≤55 75 (78.1) 153 (92.2)
Donor gender
 Female 22 (22.4) 88 (51.5) 0.27 (0.15–0.47) <0.001
 Male 76 (77.6) 83 (48.5)
HLA-A+B+DR mismatch
 >2 75 (76.5) 144 (84.2) 0.61 (0.33–1.14) 0.143
 ≤2 23 (13.5) 27 (15.8)
WIT (min)
 >45 42 (43.8) 54 (32.5) 1.59 (0.95–2.68) 0.084
 ≤45 54 (56.3) 111 (66.8)
CIT (h)
 >12 84 (85.7) 33 (19.3) 25.09 (13.44–53.09) <0.001
 ≤12 14 (14.3) 138 (80.7)
EBL (mL)
 >500 28 (28.6) 23 (13.5) 2.57 (1.38–4.79) 0.003
 ≤500 70 (71.4) 148 (86.5)
Perioperative Hb decrement (g/dL)
 >1.35 53 (54.1) 42 (24.6) 3.62 (2.13–6.14) <0.001
 ≤1.35 45 (45.9) 129 (75.4)
Percentage of Hb decrement (%)
 >12.50 51 (52.0) 42 (24.6) 3.33 (1.97–5.65) <0.001
 ≤12.50 47 (48.0) 129 (75.4)